KR20020064088A - Light ripening of drug·food - Google Patents

Light ripening of drug·food Download PDF

Info

Publication number
KR20020064088A
KR20020064088A KR1020010004700A KR20010004700A KR20020064088A KR 20020064088 A KR20020064088 A KR 20020064088A KR 1020010004700 A KR1020010004700 A KR 1020010004700A KR 20010004700 A KR20010004700 A KR 20010004700A KR 20020064088 A KR20020064088 A KR 20020064088A
Authority
KR
South Korea
Prior art keywords
weight
red
ceramic body
paper
food
Prior art date
Application number
KR1020010004700A
Other languages
Korean (ko)
Inventor
최원철
Original Assignee
동의제약 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 동의제약 주식회사 filed Critical 동의제약 주식회사
Priority to KR1020010004700A priority Critical patent/KR20020064088A/en
Publication of KR20020064088A publication Critical patent/KR20020064088A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/30Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B33/00Clay-wares
    • C04B33/02Preparing or treating the raw materials individually or as batches
    • C04B33/13Compounding ingredients
    • C04B33/131Inorganic additives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PURPOSE: A method for treating crude drug and food by irradiating far infrared rays with a ceramic body to the crude drug and food is provided. Whereby, antioxidant function and anticancer function of the crude drug and food selected from loess, Amydae Carapax, Psoraleae semen, Biota orientalis, Artemisiae asiaticae Herba, Eugenia caryophyllus, walnut skin, Acanthopanax Senticosus or the like are increased. CONSTITUTION: Loess is soaked in water, mixed with 20 to 30% by weight of gypsum while heating at 90 to 105deg.C, based on the weight of the loess, mixed with Fossilia Ossis Mastodi and talc fewer than the amount of the gypsum, and cooled to form a coagulum, which is ground, mixed with 5 to 10% by weight of rosin and edible glue no fewer than the amount of the rosin and calcined to a rough molded product. Actinolite is steeped in water at 95 to 115deg.C for 2 to 3hr and the rough molded product is soaked therein and dried to produce a ceramic body that is used for treatment of crude drug and food.

Description

약재·식품의 광숙성 방법{LIGHT RIPENING OF DRUG·FOOD}Light ripening method of medicine, food {LIGHT RIPENING OF DRUG, FOOD}

본 발명은 원적외선을 이용하여 약재 및/또는 식품을 처리하는 방법(이하, 단지 단지 '광숙성법'이라 한다.)에 관한 것이다. 보다 상세하게는 원적외선을 특정한 세라믹체를 통하여 처리하고자 하는 약재 및/또는 식품에 조사함으로써 약재 및/또는 식품에 항암성을 증가시키는 광숙성법에 관한 것이다.The present invention relates to a method of treating medicinal herbs and / or foods using far infrared rays (hereinafter only referred to as the 'photoaging method'). More specifically, the present invention relates to a photoaging method of increasing anticancer properties of medicines and / or foods by irradiating far-infrared rays to medicines and / or foods to be treated through a specific ceramic body.

암은 현재 인류 문명 사회에서 해결해야할 가장 큰 문제 중 하나이며 암을 치료하기 위한 많은 연구가 이루어져 왔다. 암 치료법으로서는 방사선 치료법, 유전자 치료법 등이 있으나, 이러한 치료법은 초기에 진단하여 발견한 경우에는 효과가 크나 암의 발생이 어느 정도 진전된 상태의 경우에는 만족할 만한 수준의 효과를 나타내지 못하는 실정이다.Cancer is one of the biggest problems to be solved in human civilization, and much research has been done to treat cancer. Cancer treatments include radiotherapy, gene therapy, and the like, but these treatments are effective when diagnosed and detected early, but do not show satisfactory effects when the development of cancer is somewhat advanced.

또한, 근래에는 한의학적으로 항암 효능을 갖는 것으로 알려진 한약을 이용하여 암을 치료하려는 항암 치료 개발에 관심이 많아지고 있다.In recent years, there is a growing interest in developing anticancer therapies for treating cancer using herbal medicines known to have anticancer efficacy.

한편, 항암 치료 방법으로서 인체에 유용한 광선인 원적외선을 이용한 방법이 많이 연구되고 있다.On the other hand, as a chemotherapy method, many methods using far-infrared rays which are useful to a human body have been researched.

광숙성이란 광에너지를 통한 숙성을 의미하며, 그 원리는 특정 파장을 이용한 공명원리를 이용한 것으로 현재 의학계에서 적외선을 인체에 조사하여 염증 치료와 혈류 개선 효능을 도모하고 있는 것이 그 예이다.Photo-aging means the ripening through light energy, and the principle is the resonance principle using a specific wavelength. For example, in the medical field, infrared radiation is irradiated to the human body to promote inflammation treatment and blood flow improving effect.

그러나, 아직까지 원적외선을 이용하여 항암성 약재 및/또는 항암 기능성 식품을 광숙성시키는 방법이 개발된 바는 없다.However, no method has yet been developed for the photosynthesis of anticancer drugs and / or anticancer functional foods using far infrared rays.

이에 본 발명의 목적은 원적외선을 이용하여 약재 및/또는 식품의 항암 효과를 증대시킬 수 있는 광숙성 방법을 제공하는데 있다.Accordingly, an object of the present invention is to provide a photomaturation method that can increase the anticancer effect of medicines and / or foods using far infrared rays.

도 1은 본 발명에 의한 광숙성법을 나타내는 개략도이다.1 is a schematic view showing a light aging method according to the present invention.

도 2a는 일반 암환자의 활성산소 측정도를 도시한 그래프, 도 2b는 보증익기탕을 복용시켜 2시간 후에 측정한 암환자의 활성산소 측정결과를 나타낸 그래프, 도 2c는 본 발명에 의한 광숙성 방법으로 광숙성시킨 보증익기탕을 복용시켜 2시간 후에 환자의 활성산소 측정결과를 나타낸 그래프이다.Figure 2a is a graph showing the measurement of free radicals of general cancer patients, Figure 2b is a graph showing the measurement results of the active oxygen of cancer patients measured after 2 hours taking Gugikgigitang, Figure 2c is a photoaging method according to the present invention It is a graph showing the results of measurement of active oxygen of the patient after taking 2 hours after taking the ripened gukgigitang.

도 3은 본 발명에 의해 제조된 약재의 항암 효과를 나타내는 그래프이다.Figure 3 is a graph showing the anticancer effect of the medicine prepared by the present invention.

본 발명에 의하면,According to the invention,

적석지를 수침시켜 습윤 적석지를 형성하는 단계;Immersing the red paper to form wet red paper;

상기 습윤 적석지를 90~105℃로 가열하면서 적석지의 중량을 기준으로 석고 20~30중량%를 혼합한 다음 그 혼합물에 상기 석고보다 적은량의 용골 및 활석을 첨가 혼합한 후 냉각시켜 응고물을 형성하는 단계;Mixing 20-30% by weight of gypsum based on the weight of the red coal paper while heating the wet red coal paper at 90-105 ° C., and then adding a smaller amount of keel and talc to the mixture to cool the mixture to form a coagulum. step;

상기 응고물을 분쇄한 후 그 응고물의 중량을 기준으로 송진 5~10중량% 및 상기 송진보다 적지않은 양의 식용 아교를 첨가 혼합한 다음, 소성시켜 초벌 성형물을 형성하는 단계;Pulverizing the coagulated product, adding and mixing 5-10 wt% of rosin and an amount of edible glue less than the rosin based on the weight of the coagulated product, and then calcining to form a primary molded product;

양기석(陽起石)을 95~115℃ 물에서 2~3시간 우려낸 다음, 그 우려낸 물에 상기 초벌 성형물을 침지시키고나서 건조하여 세라믹체로 제조하는 단계; 및Preparing a ceramic body by immersing Yang Ki-Suk in the water of 95-115 ° C. for 2 to 3 hours, and then immersing the primitive molded product in the water soaked. And

상기 세라믹체 하부에 처리하고자 하는 약재 및/또는 식품을 배치하고 상기 세라믹체 상부로부터 상기 세라믹체를 통해 상기 약재 및/또는 식품에 원적외선을 조사하는 단계;Placing a medicine and / or food to be treated under the ceramic body and irradiating far infrared rays to the medicine and / or food from the ceramic body through the ceramic body;

를 포함하는 광숙성 방법이 제공된다.There is provided a photosynthesis method comprising a.

이하, 본 발명에 대하여 상세히 설명한다.EMBODIMENT OF THE INVENTION Hereinafter, this invention is demonstrated in detail.

원적외선을 이용한 약재 및/또는 식품의 광숙성에 관한 것으로, 처리하고자 하는 항암성 약재 및/또는 식품에 특정한 세라믹체를 통하여 원적외선을 조사하여 광숙성시킴으로써 처리된 약재 및/또는 식품의 항암효능이 증대됨을 발견하였다.It relates to the photoaging of medicines and / or foods using far-infrared rays, wherein the anti-cancer efficacy of the treated medicines and / or foods is increased by irradiating far-infrared rays through a ceramic body specific to the anti-cancer medicines and / or foods to be treated. Was found.

처리하고자 하는 약재 및/또는 식품에 항암 효능을 부여하기 위해 원적외선 조사시 원적외선이 통과되는 세라믹체는 적석지, 석고, 용골, 활석, 송진 및 식용 아교를 각각 처리, 혼합 및 분쇄하여 제조한다.In order to give anti-cancer efficacy to medicines and / or foods to be treated, ceramics through which far-infrared light passes through far-infrared irradiation are manufactured by treating, mixing, and grinding red paper, gypsum, keel, talc, rosin, and edible glue, respectively.

먼저, 적석지를 수침시켜 습윤 적석지를 형성한다. 적석지는 중화기능과 인체 소화기를 안정시키는 작용을 한다. 적석지를 수침시키는 이유는 다음에 첨가되는 석고와 잘 배합하기위해서이다. 바람직하게는 적석지를 2~3일간 수침시켜 함수율 200∼300%의 습윤 적석지를 제조한다. 적석지가 충분한 함수율을 갖기위해 최소 2일 수침시킨다. 그러나 3일이상 수침시키면 함수율이 많아져 석고배합이 잘 안된다. 또한 적석지가 함수율 200%이하에서는 석고와 반응이 잘 안되며 함수율 300%이상에서는 이후에 첨가되는 활석과의 반응을 저해한다.First, wet red paper is formed by soaking red paper. Redwood paper has a neutralizing function and stabilizes the human digestive system. The reason for immersing the red paper is to mix well with the next gypsum added. Preferably, wet red paper having a water content of 200 to 300% is prepared by soaking the red paper for 2-3 days. Allow the sedimentary soil to soak for at least two days to have sufficient moisture content. However, more than three days of soaking water content increases gypsum combination is not good. It is also difficult to react with gypsum at less than 200% water content, and inhibits the reaction with talc added at water content above 300%.

상기 습윤 적석지를 90∼105℃로 가열하면서 적석지의 중량을 기준으로 석고 20∼30중량%를 첨가하여 혼합한다. 여기서 습윤 적석지를 가열하는 이유는 상기와 같은 가열 조건에서 적석지의 수분이 거의 건조되려할 때 적석지와 석고가 가장 잘 혼합되기 때문이다. 또한 석고 첨가 혼합시 석고의 첨가량이 적석지의 중량을 기준으로 20중량%이하 또는 30중량%이상이면 이후에 첨가되는 용골과 혼합이 잘 이루어지지 않는다. 바람직하게는 적석지의 중량을 기준으로 석고 20~25중량%를 첨가한다. 석고는 호북산 석고가 바람직하다.20-30% by weight of gypsum is added and mixed based on the weight of the red paper while the wet red paper is heated to 90 to 105 ° C. The reason for heating the wet red paper is that the red paper and the gypsum are best mixed when the moisture of the red paper is almost dried under the above heating conditions. In addition, when the amount of gypsum added is less than 20% by weight or 30% by weight or more based on the weight of red coal paper, it is difficult to mix with the keel to be added later. Preferably 20 to 25% by weight of gypsum is added based on the weight of red paper. The gypsum is preferably Hubei gypsum.

그 다음, 상기 혼합물이 응고되기 시작할 때 상기 혼합물에 상기 석고보다 적은량의 용골 및 활석을 첨가 혼합한 후 냉각시켜 응고물을 형성한다. 바람직하게 적석지의 중량을 기준으로 용골 1.5∼2중량% 및 활석 1.5∼2중량%을 첨가하여 혼합한다.Then, when the mixture begins to solidify, a smaller amount of keel and talc is added to the mixture than the gypsum, followed by cooling to form a solid. Preferably, the mixture is added by adding 1.5 to 2% by weight of keel and 1.5 to 2% by weight of talc based on the weight of red coal paper.

용골은 적석지를 안정화시키는 작용을 하며, 활석은 적석지의 중화기능을 배가시키는 작용을 한다. 이때 용골과 활석의 첨가량을 동일하게 맞추는 것이 바람직하다. 상기 용골과 활석의 첨가량이 같아야 적석지와 반응이 잘 되어 응고되며 어느 한 쪽이 많으면 응고되지 않고 카라멜화 되는 문제가 있다.The keel acts to stabilize the red tide, and the talc doubles the neutralization function of the red tide. At this time, it is preferable to match the addition amount of keel and talc equally. The amount of the keel and the talc should be the same, so that it reacts well with the red tide and solidifies. If one of them is large, there is a problem of caramelization without solidification.

상기 응고물을 분말로 분쇄한 후, 그 응고물의 중량을 기준으로 송진 5∼10중량% 및 상기 송진보다 적지않은 양의 식용 아교를 첨가 혼합한 다음, 소성시켜 초벌 성형물을 형성한다. 송진은 분말의 정화기능을 높여주며 식용 아교는 비뇨기 계통을 안정시키는 작용을 하며 적석지의 효능을 유지시켜준다. 송진의 첨가량이 상기 응고물의 중량을 기준으로 5중량%미만 또는 10중량%이상으로 첨가되는 경우, 분말의 완전 경화가 이루어지지 않는다. 또한 식용 아교의 첨가량이 상기 송진보다 많아지면 송진이 굳게된다. 바람직하게 상기 응고물의 중량을 기준으로 송진 5~6중량% 및 식용 아교 7~8중량%로 첨가된다. 상기 초벌 성형물 형성시 바람직한 소성 조건은 280~300℃에서 5~6시간이다.After the coagulum is pulverized into powder, 5-10% by weight of rosin and an amount of edible glue less than the rosin are added and mixed, and then calcined to form a primary molded product. Rosin enhances the cleansing function of the powder, and food glue stabilizes the urinary system and maintains the efficacy of red paper. When the addition amount of the rosin is added in less than 5% by weight or 10% by weight or more based on the weight of the coagulant, complete curing of the powder is not achieved. In addition, rosin is hardened when the amount of food glue added is larger than the rosin. Preferably it is added 5 to 6% by weight rosin and edible glue 7 to 8% by weight based on the weight of the coagulum. Preferred firing conditions for forming the primary molded product are 5 to 6 hours at 280 to 300 ° C.

그 후, 양기석을 우려낸 물에 상기 초벌 성형물을 침지시키고나서 건조하여 세라믹체로 제조한다. 양기석은 적석지에 스며들어 적석지의 약성을 상승시키는 작용을 한다(적석지와 양기석은 MRA파동검사결과시 파장공명이 가장 잘 이루어짐.). 여기서, 상기 양기석을 우려낸 물은 양기석을 95∼115℃의 물에서 최소 2시간동안 우려내어 준비한다. 양기석을 우려낼 때 증류수의 온도가 상기 범위의 온도에서 가장 잘 우러나오며, 양기석을 우려내는 시간이 2시간이하인 경우 양기석 성분이 잘 우러나오지 않는다. 바람직하게 양기석을 우려내는 시간은 2~3시간이다.Thereafter, the primitive molded product is immersed in water in which quantitative stone is soaked, and then dried to prepare a ceramic body. Yanggi stone penetrates into the red rock and increases the weakness of the red rock (the red and yellow rocks are the best in wavelength resonance when MRA wave test results). Here, the water brewed with the positron is prepared by brewing the mutant with 95-115 ° C. for at least 2 hours. The temperature of distilled water is best at the temperature of the above range when brewing the positron, and if the time of brewing the quantitative stone is less than 2 hours, the positron component does not come out well. Preferably, the time to boil the fern is 2-3 hours.

상기 성형물을 침수시킬 때 함수율 25~30%로 침수시키는 것이 바람직하다.When the molded product is submerged, it is preferable to submerge it at a water content of 25 to 30%.

그 다음, 상기 광숙성용 세라믹체 원적외선등하에 25~30cm의 간격을 두고 배치시키고, 그 하부에는 항암성 및 항산화 효능을 부여하기 위해 처리하고자 하는약재 및/또는 식품을 배치시켜 원적외선이 상기 광숙성용 세라믹 분말을 투과하여 상기 약재 및/또는 식품에 조사되도록 한다. 상기 광숙성용 세라믹 분말과 원적외선등과의 거리가 25㎝보다 가까운 경우에는, 광숙성하고자 하는 약재 및/또는 식품이 원적외선등의 고온에 의해 변성되며 30㎝이상인 경우에는 파장 숙성이 약하게 나타난다. 250W의 원적외선등이 바람직하다.Subsequently, the photo-maturated ceramic body is placed at a distance of 25-30 cm under the infrared light, and the lower portion of the photo-maturation is placed by placing a medicine and / or food to be treated to impart anticancer and anti-oxidant efficacy. Permeate ceramic powder to be irradiated to the medicine and / or food. When the distance between the photoaging ceramic powder and the far infrared ray is closer than 25 cm, the medicine and / or food to be matured is denatured by the high temperature of the far infrared ray, and the wavelength ripening is weak when it is 30 cm or more. A far infrared ray lamp of 250 W is preferable.

상기 세라믹체는 분쇄하여 세라믹분말로 제조할 수 있다. 상기 세라믹체 또는 세라믹분말을 원적외선하에 배치시킬 때 적절한 두께는 2~3mm이다.The ceramic body may be pulverized to produce a ceramic powder. When the ceramic body or ceramic powder is disposed under far infrared rays, an appropriate thickness is 2 to 3 mm.

도 1은 본 발명에 의한 약재 및/또는 식품의 광숙성처리법을 나타내는 개략도이다.1 is a schematic view showing a photo-aging treatment method of medicines and / or foods according to the present invention.

도 1에서와 같이 원적외선은 광숙성용 세라믹 분말의 상부에서 세라믹 분말을 통하여 처리하고자 하는 약재 및/또는 식품에 조사될 수 있다.As shown in FIG. 1, far infrared rays may be irradiated to medicines and / or foods to be treated through ceramic powders on top of the photo-aging ceramic powders.

원적외선을 조사받은 상기 광숙성용 세라믹 분말은 고유의 파장을 발산하며 이것이 하부의 처리하고자 하는 약재 및/또는 식품에 전달된다. 원적외선은 체내 세포공명유도광선으로 적합하며 할로겐이나 기타 온열 등은 적석지 분말의 광숙성을 저해한다.The photo-aging ceramic powder irradiated with far infrared rays emits its own wavelength and is transmitted to the medicine and / or food to be treated below. Far infrared rays are suitable for induction of cell resonance in the body, and halogens and other heats may inhibit the maturity of the redwood powder.

본 발명의 광숙성에 의해 항암기능이 부여되는 약재로는 이로써 한정하는 것은 아니지만, 별갑, 파고지, 참옻, 측백엽, 애엽, 정향, 호도피, 홍유송진, 복령, 당귀, 천공, 작약, 감초, 승마, 시호, 가시오가피 및 홍해삼분을 포함한다.Herbs that are provided with anticancer function by photosynthesis of the present invention is not limited to this, but tortoiseshell, pagoji, sesame, baekyeop, love leaf, cloves, hodopi, hongsongjin, bokyeong, donkey, perforation, peony, licorice, horse riding Contains seahawks, thorns, and red sea ginseng.

또한, 본 발명에 의한 방법은 어떠한 음식물에도 적용하여 항암성 기능식품의 제조에 적용될 수 있다.In addition, the method according to the invention can be applied to the production of anti-cancer functional food by applying to any food.

이하, 실시예를 통해 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail through examples.

실시예 1: 광숙성용 세라믹 분말의 제조Example 1 Preparation of Ceramic Powder for Photoaging

적석지(赤石脂, 한약재의 일종) 300g을 물에 70시간 담그어 함수율 200%내외의 습윤 적석지를 제조하였다. 그 다음 상기 습윤 적석지를 100℃에서 20분내외로 가열하면서 호북산 석고 60g을 첨가하여 혼합한 다음, 10분후 적석지와 석고가 응고되는 시점에서 용골 4.5g 및 활석 4.5g을 첨가하여 혼합한 다음 56∼60℃ 온도로 가열을 마치고 상온에서 냉각 응고시켜 응고물을 제조하였다.300 g of red stone paper (赤石脂, a kind of herbal medicine) was soaked in water for 70 hours to prepare a wet red paper of about 200% moisture content. Then, the wet red coal paper was heated at 100 ° C. within 20 minutes, and then mixed with 60 g of Hubei gypsum, and after 10 minutes, when the red paper and gypsum were solidified, 4.5 g of keel and 4.5 g of talc were added and mixed. After the heating to 56 ~ 60 ℃ temperature it was cooled and solidified at room temperature to prepare a coagulum.

이 응고물을 분쇄하여 분말로 만들고 여기에 송진 20g과 식용 아교 20g을 첨가하고 혼합한 다음 12월에 내리는 눈녹인 물인 납설수를 사용하여 함수율이 20-30%이 되도록 반죽하였다. 그 후 이를 벽돌형태로 성형한 다음 300℃의 도자기로에서 6시간동안 구워 초벌 성형하였다.The coagulum was pulverized to a powder, and 20 g of rosin and 20 g of edible glue were added thereto, mixed, and kneaded so that the water content was 20-30% using lead snow water, which is snow melted in December. After that, it was molded into bricks, and then baked for 6 hours in a ceramic oven at 300 ° C. for primary molding.

그 후, 양기석(陽起石)을 100℃에서 130분 우려낸 물에 상기한 바와 같이 제조된 벽돌형태의 성형물을 함수율 30%내외가 되도록 5시간동안 침수시켰다. 그 다음 상온에서 건조시키고 분쇄하여 세라믹 분말로 제조하였다.Subsequently, the brick-shaped molded product prepared as described above was immersed for 5 hours in water having boiled yang seok stone at 100 ° C. for 130 minutes to have a water content of about 30%. Then dried at room temperature and ground to prepare a ceramic powder.

실시예 2: 광숙성처리Example 2: Photoaging

도 1에 나타낸 바와 같이, 상기 실시예 1에서 제조된 세라믹분말을 용기에하기 표 1의 두께로 각각 적층하고 그 상부에서 원적외선등(필립스 250W)을 상기 세라믹 분말을 통하여 처리하고자하는 한약재에 하기 표 1의 시간동안 조사하였다.As shown in Fig. 1, the ceramic powder prepared in Example 1 was laminated on the container in the thickness of the following Table 1, and the far-infrared light (Philips 250W) on the top of the herbal medicine to be treated through the ceramic powder Irradiation was made for 1 hour.

한약제 혼합물은 별갑 3중량%, 파고지 3중량%, 측백엽 5중량%, 애엽 5중량%, 정향 0.5중량%, 호도피 1.5중량%, 거유송진 15중량%, 홍삼 2중량%, 복령 2중량%, 가시오가피 15중량%, 당귀 3중량%, 참옻 35중량%, 작약 2중량%, 감초 1중량%, 승마 1.5중량%, 시호 0.5중량% 및 홍해삼분 5중량%를 포함한다.Herbal medicine mixture is 3% by weight of Tortoiseshell, 3% by weight of pagoji, 5% by weight of white leaf, 5% by weight of young leaves, 0.5% by weight of clove, 1.5% by weight of larvae, 15% by weight of red pine ginseng, 2% by weight of red ginseng, 2% by weight of Fuling, 15% by weight, Angelica 3% by weight, 35% by weight of oak, 2% by weight of peony, 1% by weight of licorice, 1.5% by weight of horse riding, 0.5% by weight of sea tiger, and 5% by weight of red sea ginseng.

실시예 3: 자기공명분석법(Magnetic Resonance Analyzer, MRA)에 의Example 3: By Magnetic Resonance Analyzer (MRA) 한 항암성 측정One anticancer measure

자기공명분석법(식물과 공명도 수치, 공명도가 높을수록 항암효능이 높은 것으로 나타남. 대한파동생명장학회 99. 7 발표자료)으로 본 발명에 의한 방법으로 처리된 발명예 1-3, 대조군 및 비교예로 처리된 약재의 악성종양 및 면역기능에 대한 공명도를 측정하여 하기 표 1에 나타내었다.Comparison of Inventive Examples 1-3, Control and Comparison with Magnetic Resonance Analysis (Plant, Resonance Number, Higher Resonance, Higher Anticancer Effect. Presented by Korean Wave Life Scholarship 99. 7) For example, by measuring the resonance for the malignant tumor and immune function of the treated medicine is shown in Table 1 below.

발명예 1-3에서 사용된 세라믹분말 및 처리하고자 하는 약재는 상기 실시예 1 및 2에 기술된 바와 같다. 단, 세라믹분말의 적층두께 및 원적외선 조사시간을 하기 표 1에 기술한 바와 같이 달리하였다.The ceramic powder used in Inventive Examples 1-3 and the medicines to be treated are as described in Examples 1 and 2 above. However, the lamination thickness and the far-infrared irradiation time of the ceramic powder were different as described in Table 1 below.

대조군으로는 원적외선을 조사하지 않은 일반 한약액(항암효능이 밝혀진 담배인삼공사 6년근 정관장 인삼 엑기스)을 사용하였으며, 비교예로는 상기 세라믹 분말을 사용하지 않고 단지 원적외선을 6시간동안 조사한 것을 제외하고는 상기 실시예 1과 같이 제조된 한약액을 사용하였다.As a control, a general herbal medicine (6 years old Jeonggwanjang ginseng extract, which has been found to have anticancer efficacy) was used, which was not irradiated with far infrared rays, and as a comparative example, except that irradiated with far infrared rays for 6 hours without using the ceramic powder. Was used as a herbal medicine prepared in Example 1.

대조군Control 발명예 1Inventive Example 1 발명예 2Inventive Example 2 발명예 3Inventive Example 3 비교예Comparative example 처리방법Treatment method 일반 한약액General Herbal Medicine 분말두께2mm원적외선-6시간 조사Powder thickness 2mm far infrared rays-6 hours irradiation 분말두께2mm원적외선-7시간 조사Powder thickness 2mm far infrared rays-7 hours irradiation 분말두께4mm원적외선-6시간 조사Powder thickness 4mm far infrared rays-6 hours irradiation 세라믹 분말사용하지 않음.원적외선-6시간 조사Ceramic powder not used Far-infrared radiation for 6 hours 악성종양1(F005)Malignant tumor 1 (F005) +9+9 +21+21 +20+20 +19+19 +11+11 면역기능2(B222)Immune function 2 (B222) +6+6 +21+21 +19+19 +16+16 +7+7

1: 악성종양은 각 부위 악성 종양에서 공통적으로 발생되는 특징 신호이다.1: Malignant tumor is a characteristic signal common to malignant tumors in each region.

2: 면역기능은 악성종양 파장을 상쇄시킬 수 있는 간섭신호로 인체에서는 치료공명파장을 의미한다.2: Immune function is an interference signal that can offset the wavelength of malignant tumor, which means the therapeutic resonance wavelength in human body.

참고:Reference:

악성종양 및 면역기능의 번호는 MRA 인식번호를 의미한다.The number of malignant tumors and immune functions refers to the MRA recognition number.

기존에 사용되는 항암제는 강력한 항암제일수록 F005 악성종양 수치가 높게 표현된다. 예)택솔 +20, 증류수 0, 북경중의대 암치료제 소저산 +15The more powerful the anticancer agent, the higher the F005 malignancy is. Ex) Taxol +20, distilled water 0, Beijing Chuo University Cancer Cure

실시예 4: 활성산소 제거능력 향상 평가Example 4: evaluation of improvement of active oxygen removal ability

본 실시예는 본 발명의 광숙성처리된 약재를 복용함으로써 체내의 유해산소인 활성산소가 현저하게 감소됨을 나타내는 것이다.This example shows that the active oxygen, a harmful oxygen in the body, is significantly reduced by taking the photo-aged herbs of the present invention.

환자(백혈병환자 19세 여 이제현)로부터 혈액을 채취하여 활성산소를 측정하였다. 활성산소 측정은 프리라디칼 측정기(미국 Bradford 연구소 BJL 제품, BJL Ultra-weak Chemiluminescence Analyzer)를 사용하여 측정하였다.Blood was collected from a patient (leukemia 19-year-old female Lee Hyun-hyeon) to measure the free radicals. Free radicals were measured using a free radical meter (BJL Ultra-weak Chemiluminescence Analyzer, manufactured by BJL, Bradford Laboratories, USA).

참옻 50중량%, 거유송진 25중량% 및 홍해삼분 25중량%로 이루어진 전탕액을환자에게 50g 복용한 후 2시간 후에 환자로부터 1㏄의 혈액을 채취하여 상기와 같은 방법으로 활성산소를 측정하였다.After taking 50g of the lactose solution consisting of 50% by weight of sesame, 25% by weight of pine rosin and 25% by weight of red sea ginseng to the patient, 1 혈액 of blood was collected from the patient and the active oxygen was measured in the same manner as described above.

한편, 상기 참옻 50%, 거유송진 25%, 홍해삼분 25% 전탕액을 실시 예 1의 광숙성 분말을 사용하여 2mm 두께로 6시간 동안 원적외선을 조사하여 광숙성시킨 다음, 상기 환자에게 50g 1회/day 복용하고, 2시간 후에 혈액을 채취하여 상기와 같은 방법으로 활성산소를 측정하였다. 그 결과를 도 2에 나타내었다.On the other hand, the 50% of the lacquer, 25% Yujin pine, 25% red sea ginseng powder 25% of the lyotropic liquid using the photoaging powder of Example 1 irradiated with far-infrared radiation for 6 hours to 2mm thickness, and then 50g once to the patient After taking 2 days / day, blood was collected and free radicals were measured in the same manner as above. The results are shown in FIG.

도 2에 나타낸 바와 같이, 환자가 본 발명의 광숙성 방법으로 광숙성된 보증익기탕을 투여받은 경우, 체내의 유해산소인 활성산소가 현저히 감소됨을 알 수 있다.As shown in FIG. 2, it can be seen that when the patient is administered Gugikgi-tang, which is matured by the photoaging method of the present invention, free radicals, which are harmful oxygen in the body, are significantly reduced.

실시예 5: 암 치료제 ACM700과 ACM700에 광숙성 처리된 약제가 첨가된 ACM900의 효능 비교.Example 5: Comparison of the efficacy of ACM700 with cancer treatment ACM700 and ACM900 added with a photo-aging drug.

표 2에 나타낸 바와 같이, 암 환자 133명에게(광혜원한방병원 내원 말기암환자) 비교약제로 사용된 ACM700(거유송진 25중량%, 참옻 50중량% 전탕액 및 홍해삼분 25중량%, 광혜원 한방병원의 처방약) 및 발명예로서 사용된 ACM900(상기 ACM700을 본 발명에 의해 광숙성 처리된 항암제)를 암 환자 133명에게 복용시키고 1년 후 생존율을 측정하여 도 3에 나타내었다.As shown in Table 2, ACM700 (25% by weight of milk rosin, 50% by weight of lacquer lactose and 25% by weight of red sea ginseng herbal medicine) used as a comparative drug for 133 cancer patients (Gwanghyewon Oriental Medical Hospital) The prescription drug) and ACM900 (anticancer agent treated with photosynthesis according to the present invention, ACM900) used as the invention example were taken to 133 cancer patients, and survival rate was measured after 1 year, and is shown in FIG. 3.

도 3에 나타낸 바와 같이, 본 발명에 의한 광숙성 방법으로 광숙성된 약재(ACM900)를 투여받은 경우, 환자들의 생존율이 76%로 가장 높았다. 이러한 생존율은 광혜원 한방병원의 처방약(ACM700, 생존율 53%)보다 높은 것이다.As shown in FIG. 3, when the photo-aging drug (ACM900) was administered by the photoaging method according to the present invention, the survival rate of patients was the highest at 76%. This survival rate is higher than that of Kwang Hye Won Oriental Medicine Hospital (ACM700, 53% survival rate).

실시예 6: 광숙성 처리된 항암제의 성능 평가Example 6 Performance Evaluation of Photosaturated Anticancer Agents

상기 실시예 5의 약재 ACM900이 각종 암세포에 대하여 미치는 항암 활성을 SRB법(Proc. Am. Assoc. Cancer Res., 30:612, 1989, Skehan 등)으로 조사하였다.The anticancer activity of the medicinal ACM900 of Example 5 against various cancer cells was examined by SRB method (Proc. Am. Assoc. Cancer Res., 30: 612, 1989, Skehan et al.).

암세포로서, 유방암 세포주 MCF7, 피부암 세포주 M14, LOX-IMVI, 중추신경계(CNV) 관련 암세포주 SNB19, 결장(colon)암 세포주 HCT116, COLO205, 위(renal) 암세포주 UO-31, 폐 암세포주 NCI-H226, A549를 사용하였다. 상기 암세포주는 10% 소태아 혈청이 포함된 RPMI 1640 배지를 사용하여 배양하였고 배양된 세포는 일주일에 한번 또는 두 번 분주하여 유지하였다. 항암활성을 측정하는데 사용된 세포농도는 3,000-6,000cells/ml이었으며, 사용된 모든 시약은 100% 디메틸설포옥사이드(demethylsulfoxide, DMSO)에 녹이고 이를 단계적으로 희석하여 시약의 농도를 10, 3, 1, 0.3, 0.1㎍/ml로 맞추었다.As cancer cells, breast cancer cell line MCF7, skin cancer cell line M14, LOX-IMVI, central nervous system (CNV) related cancer cell line SNB19, colon cancer cell line HCT116, COLO205, renal cancer cell line UO-31, lung cancer cell line NCI- H226, A549 was used. The cancer cell line was cultured using RPMI 1640 medium containing 10% fetal bovine serum, and the cultured cells were maintained by dispensing once or twice a week. The cell concentration used to measure anticancer activity was 3,000-6,000 cells / ml. All the reagents used were dissolved in 100% dimethylsulfoxide (DMSO) and diluted in stages to increase the concentration of the reagents. 0.3 and 0.1 µg / ml.

세포의 수를 측정하여 일정한 농도로 96-웰 플레이트에 분주하고 하루가 경과한 다음, 세포가 나타내는 기본적인 흡광도를 확인하는데 필요한 Tz(Time/Zero) 플레이트로서 시료를 처리할 플레이트와 동일한 세포 농도를 가진 다른 플레이트를 50% TCA(Trichloroacetic Acid, 고정용액)를 사용하여 고정하였다. 그리고 시료를 처리할 플레이트는 시료의 최종 농도를 0.1% DMSO로 맞추어 5가지 시료 농도로 처리하였다. Tz 플레이트는 1시간이 경과하면 수돗물(Tap Water)로 세척하고, 시료를 처리한 플레이트는 2일이 경과한 다음 50% TCA를 웰당 50㎕씩 처리하여 고정하고 역시 1시간이 경과하면 수돗물로 세척하였다. 세척한 플레이트는 상온에서 건조시키고 그 후 0.4% SRB 용액(1% 아세트산에 용해되어 있는 용액)을 웰당 100㎕씩 가한 다음 30분이 경과하면 1% 아세트산 용액으로 세척하였고 이를 다시 상온에서 건조시켰다.After measuring the number of cells and dispensing them in 96-well plates at a constant concentration, and after one day, the Tz (Time / Zero) plate required to determine the basic absorbance of the cells, having the same cell concentration as the plate to be treated. The other plate was fixed using 50% TCA (Trichloroacetic Acid, fixed solution). The plate to be treated with the sample was treated with five sample concentrations by adjusting the final concentration of the sample to 0.1% DMSO. Tz plate was washed with tap water after 1 hour, and the plate treated with sample was fixed with 50 μl of 50% TCA per well after 2 days, and also with tap water after 1 hour. It was. The washed plate was dried at room temperature, and then 100 μl of 0.4% SRB solution (solution dissolved in 1% acetic acid) was added per well, and then washed with 1% acetic acid solution after 30 minutes and dried again at room temperature.

그 다음, 10mM 트리스 염기(pH 10.5)를 웰당 10㎕씩 가하여 다시 용해시키고, 효소면역 측정법(enzyme-linked immunosorbent assay, ELISA)으로 ELISA 해독기를 사용하여 540nm에서 흡광도를 측정하였다. 이때 GI50(㎍/㎖)은 암세포의 성장을 50% 억제하는 화합물의 농도를 나타낸다. 비교군으로서 아드리아마이신(adriamycin)을 사용하여(10∼0.1㎍/㎖) 비교하였다. 비교 결과 아드리아마이신(기존 강력 항암제)과 비교시 대등한 효능이 나타났고 천연물에서는 대단한 효능이 나타났다.Then, 10 μl tris base (pH 10.5) was added to 10 μl per well to dissolve again, and the absorbance was measured at 540 nm using an ELISA reader by an enzyme-linked immunosorbent assay (ELISA). In this case, GI 50 (μg / ml) represents the concentration of the compound that inhibits the growth of cancer cells by 50%. Comparison was made using adriamycin (10-0.1 µg / ml) as a comparative group. Compared with adriamycin (an existing potent anticancer agent), the results were comparable, and the natural product showed great efficacy.

그 결과를 하기 표 3에 나타내었다.The results are shown in Table 3 below.

암세포주Cancer cell line 암세포 성장 억제 효과(GI50(㎍/ml))Cancer cell growth inhibitory effect (GI 50 (㎍ / ml)) A549A549 2.022.02 NCI-H226NCI-H226 4.534.53 UO-31UO-31 1.061.06 Colo205Colo205 2.512.51 HCT116HCT116 2.192.19 SNB19SNB19 5.195.19 LOX-IMVILOX-IMVI 3.433.43 M14M14 1.291.29 MCF7MCF7 2.172.17

표 3에 나타낸 바와 같이, 본 발명의 광숙성 처리된 약재 ACM900은 9종의 암세포에 대해 성장을 억제하는 강한 활성을 나타냄을 확인하였다.As shown in Table 3, it was confirmed that the photosynthetic medicinal herbs ACM900 of the present invention showed a strong activity of inhibiting growth against nine cancer cells.

원적외선 및 본 발명의 세라믹 분말을 이용하여 약재 및/또는 식품을 광숙성 처리함으로써 약재 및/또는 식품의 항산화 기능, 항암 기능이 증대된다.The anti-aging and anti-cancer functions of the medicinal herbs and / or foods are increased by photoaging the medicinal herbs and / or foods using the far-infrared rays and the ceramic powder of the present invention.

Claims (14)

적석지를 수침시켜 적석지를 습윤시키는 단계;Immersing the red paper to wet the red paper; 상기 습윤된 적석지를 90~105℃로 가열하면서 적석지의 중량 기준으로 석고 20~30중량%를 혼합한 다음 그 혼합물에 상기 석고보다 적은량의 용골 및 활석을 첨가 혼합한 후 냉각시켜 응고물을 형성하는 단계;Mixing 20-30% by weight of gypsum on the basis of the weight of the red coal paper while heating the wet red coal paper to 90 ~ 105 ℃ and then adding and mixing a smaller amount of keel and talc than the gypsum in the mixture to cool to form a coagulum step; 상기 응고물을 분쇄한 후 그 응고물의 중량 기준으로 송진 5~10중량% 및 상기 송진보다 적지않은 양의 식용 아교를 첨가 혼합한 다음 소성시켜 초벌 성형물을 형성하는 단계;Pulverizing the coagulated product, adding and mixing 5-10 wt% of rosin and an amount of edible glue less than the rosin based on the weight of the coagulated product, and then firing to form a primary molded product; 양기석(陽起石)을 95~115℃ 물에서 2~3시간 우려낸 다음, 그 우려낸 물에 상기 초벌 성형물을 침지시키고나서 건조하여 세라믹체로 제조하는 단계; 및Preparing a ceramic body by immersing Yang Ki-Suk in the water of 95-115 ° C. for 2 to 3 hours, and then immersing the primitive molded product in the water soaked. And 상기 세라믹체 하부에 처리하고자 하는 약재 및/또는 식품을 배치하고 상기 세라믹체 상부로부터 상기 세라믹체를 통해 상기 약재 및/또는 식품에 원적외선을 조사하는 단계;Placing a medicine and / or food to be treated under the ceramic body and irradiating far infrared rays to the medicine and / or food from the ceramic body through the ceramic body; 를 포함하는 광숙성 방법.Photosaturation method comprising a. 제 1항에 있어서, 나아가 상기 세라믹체 제조후, 상기 세라믹을 미분쇄하여 세라믹 분말로 형성시키는 단계;를 포함함을 특징으로 하는 방법.The method of claim 1, further comprising, after manufacturing the ceramic body, pulverizing the ceramic to form a ceramic powder. 제 1항에 있어서, 상기 약재 및/또는 식품은 별갑, 파고지, 측백엽, 애엽,정향, 호도피, 가시오가피, 홍삼, 복령, 당귀, 천공, 작약, 감초, 참옻, 승마, 시호, 거유송진 및 홍해삼분으로부터 선택됨을 특징으로 하는 방법.The method of claim 1, wherein the medicinal herbs and / or foods are tortoiseshell, pagoji, baekryeop, larvae, cloves, hawthorn, prickly pear, red ginseng, bokyeong, donkey, perforated, peony, licorice, sesame, horseback riding, shiho, big pine gin and red sea ginseng Selected from minutes. 제 1항에 있어서, 상기 습윤 적석지의 함수율은 200~300%임을 특징으로 하는 방법.The method of claim 1, wherein the water content of the wet calcined paper is 200 to 300%. 제 1항에 있어서, 상기 석고의 혼합량은 적석지의 중량을 기준으로 20~25중량%임을 특징으로 하는 방법.The method of claim 1, wherein the mixing amount of gypsum is 20 to 25% by weight based on the weight of red paper. 제 1항에 있어서, 상기 용골의 혼합량은 적석지의 중량을 기준으로 1.5~2중량%임을 특징으로 하는 방법.The method of claim 1, wherein the mixing amount of the keel is 1.5 to 2% by weight based on the weight of the red paper. 제 1항에 있어서, 상기 활석의 혼합량은 적석지의 중량을 기준으로 1.5~2중량%임을 특징으로 하는 방법.The method of claim 1, wherein the mixed amount of talc is 1.5 to 2% by weight based on the weight of the red paper. 제 1항에 있어서, 상기 송진의 혼합량은 응고물의 중량을 기준으로 5~6중량%임을 특징으로 하는 방법.The method of claim 1, wherein the mixing amount of the rosin is 5 to 6% by weight based on the weight of the coagulant. 제 1항에 있어서, 상기 식용 아교의 혼합량은 응고물의 중량을 기준으로 7~8중량%임을 특징으로 하는 방법.The method of claim 1, wherein the mixing amount of the edible glue is 7 to 8% by weight based on the weight of the coagulant. 제 1항에 있어서, 상기 초벌 성형물 형성시 소성 조건은 280~300℃에서 5~6시간임을 특징으로 하는 방법.The method of claim 1, wherein the firing conditions for forming the primary molding are 5 to 6 hours at 280 to 300 ℃. 제 1항에 있어서, 나아가 양기석을 우려낸 물에 상기 초벌 성형물을 침지시킬 때 함수율은 25~30%임을 특징으로 하는 방법.The method according to claim 1, wherein the water content is 25 to 30% when the priming molding is immersed in the water brewing ferrite. 제 1항에 있어서, 나아가 상기 세라믹체를 배치시킬 때, 상기 세라믹체의 두께는 2~3mm임을 특징으로 하는 방법.The method of claim 1, wherein when the ceramic body is disposed, the thickness of the ceramic body is 2 to 3 mm. 제 1항에 있어서, 나아가 상기 세라믹체를 배치시킬 때, 원적외선과 의 거리는 25~30cm임을 특징으로 하는 방법.The method according to claim 1, wherein when disposing the ceramic body, the distance from far infrared rays is 25 to 30 cm. 제 1항에 있어서, 상기 세라믹체는 분말형태를 포함함을 특징으로 하는 방법.The method of claim 1, wherein the ceramic body comprises a powder form.
KR1020010004700A 2001-01-31 2001-01-31 Light ripening of drug·food KR20020064088A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020010004700A KR20020064088A (en) 2001-01-31 2001-01-31 Light ripening of drug·food

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010004700A KR20020064088A (en) 2001-01-31 2001-01-31 Light ripening of drug·food

Publications (1)

Publication Number Publication Date
KR20020064088A true KR20020064088A (en) 2002-08-07

Family

ID=27692951

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020010004700A KR20020064088A (en) 2001-01-31 2001-01-31 Light ripening of drug·food

Country Status (1)

Country Link
KR (1) KR20020064088A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100620126B1 (en) * 2004-04-28 2006-09-14 동양종합식품주식회사 A method for producing bacon by using poria cocos and salts keeping far-infrared rays and a bacon produced by the same method
KR100896235B1 (en) * 2007-07-16 2009-05-08 한국원자력연구원 A method reducing allergy of rhus veniciflua sap using radiation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100620126B1 (en) * 2004-04-28 2006-09-14 동양종합식품주식회사 A method for producing bacon by using poria cocos and salts keeping far-infrared rays and a bacon produced by the same method
KR100896235B1 (en) * 2007-07-16 2009-05-08 한국원자력연구원 A method reducing allergy of rhus veniciflua sap using radiation

Similar Documents

Publication Publication Date Title
KR101011028B1 (en) Composition for Promoting Proliferation of Hematopoietic Stem Cell Containing Inonotus obliquus extract, Phellinus linteus extract and Ganoderma lucidum extract
CN103211974B (en) Medicinal liquor for improving immunity and application thereof
CN104774721A (en) Health-care wine capable of invigorating qi and tonifying kidney and preparation method thereof
CN101816653A (en) Application of berberine in preparing tumor radio sensitization medicine
KR20020064088A (en) Light ripening of drug·food
Lee et al. Inhibition of nitric oxide synthase expression in activated microglia and peroxynitrite scavenging activity by Opuntia ficus indica var. saboten
KR20120059258A (en) Oriental medicine extract having biological activity and manufacturing method thereof
CN109010495B (en) Traditional Chinese medicine composition and preparation method and application thereof
CN103877237A (en) Application of eight-treasure particle in preparation of drugs used for treating brain glioma
KR20160086457A (en) Composition comprising alcohol extract of GamiBangkeehwangkeetang for preventing and treating a rheumatoid arthritis
CN105168306A (en) Pharmaceutical composition for promoting traumatic fracture coalescence
TWI488638B (en) Antimicrobial activity of Pennisetum active substance, preparation method and application thereof
CN101450190A (en) Traditional Chinese medicine preparation for treating malignancy
KR20050001730A (en) Composition for prevention and treatment of cancer
CN109620911B (en) Traditional Chinese medicine composition capable of improving neutropenia after chemotherapy and application thereof
CN104543986A (en) Formula of hericium erinaceus soup capable of activating blood circulation and nourishing heart and production method of hericium erinaceus soup
CN109646493A (en) A kind of antineoplastic pharmaceutical compositions and its preparation method and application
Arcone et al. Inhibition of Interleukin-6 Dependent Metalloproteinases-9/2 Expression in Cancer Cells by Diet Polyphenols
CN109820879A (en) Antrodia camphorata extract, the preparation method of Antrodia camphorata composition and medical composition
KR101985965B1 (en) Pharmaceutical composition for preventing or treating side effects induced by cisplatin comprising mixed herbal extract
Gao The impact of Fengcheng Spatholobus spatholobi on breast cancer
TWI400079B (en) Antimicrobial activity of Pennisetum active substance, preparation method and application thereof
RU2238747C2 (en) Agent for prophylaxis and treatment of urogenital system based on forgotten french honey-suckle roots and/or tea french honey-suckle roots (variants) and method for their preparing
CN107536053B (en) Antiemetic food
Awedat et al. EVALUATION OF THE POTENTIAL ANTI-CARCINOGENIC EFFECT OF ETHANOLIC CAPPARIS SPINOSA L. LEAVES EXTRACT ON ORAL SQUAMOUS CELL CARCINOMA CELL LINE (SCC-4)

Legal Events

Date Code Title Description
N231 Notification of change of applicant
WITN Withdrawal due to no request for examination